Homologous Recombination Deficiency in Triple-Negative Breast Cancer: Potential Benefit of a New Target. Nakamura S. Ann Surg Oncol 2022 Nov 18. doi: 10.1245/s10434-022-12329.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Nakamura S. Homologous Recombination Deficiency in Triple-Negative Breast Cancer: Potential Benefit of a New Target. Ann Surg Oncol 2022 Nov 18. doi: 10.1245/s10434-022-12329.
PMID: 36400890